Image guided radiation therapy: Clinical Trials

15 trials of Image guided radiation therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting, 3 active not recruiting, 3 terminated, 2 suspended. 7 Phase 2, 4 Phase 3, 3 Not applicable, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Active not recruiting 3, Recruiting 2, Completed 1, Withdrawn 1
Phase 34Active not recruiting 1, Recruiting 1, Suspended 1, Terminated 1
Not applicable3Recruiting 1, Terminated 1, Unknown 1
Phase 13Active not recruiting 1, Suspended 1, Terminated 1

Follow this drug Literature Review of Image guided radiation therapy trials Research Report on Image guided radiation therapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase II Study of Daily Adaptive Radiotherapy for Submandibular Gland-sparing in Head and Neck Cancer
Daily adaptive radiation therapy, Image guided radiation therapy - Squamous Cell Cancer of Head and Neck (SCCHN)
Not applicableRecruitingUniversity Health Network, Toronto502025-10-152026-03-04
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Best Practice, Biospecimen Collection, Cisplatin - Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Phase 2RecruitingNRG Oncology982025-06-232026-08-17
Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer
Biospecimen Collection, Cemiplimab, Computed Tomography - Eyelid Squamous Cell Carcinoma, Recurrent Eyelid Squamous Cell Carcinoma
Phase 3SuspendedNational Cancer Institute (NCI)4202025-02-182026-10-20
Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial
Biopsy, Biospecimen Collection, Computed Tomography - Prostate Adenocarcinoma
Phase 2RecruitingSean Sachdev502024-09-062026-06-05
Biology-Guided Radiation Therapy for the Treatment of Patients With Bone Metastases
Computed Tomography, Image Guided Radiation Therapy, Positron Emission Tomography - Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Solid Neoplasm
Phase 1SuspendedCity of Hope Medical Center242024-08-252026-10-20
Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer
Biospecimen Collection, Carboplatin, Chest Radiography - Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2WithdrawnECOG-ACRIN Cancer Research Group2024-04-122024-07-25
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Carboplatin, Cisplatin, Computed Tomography - Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8
Phase 3RecruitingNRG Oncology4742023-07-122026-08-17
De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer
Biopsy Procedure, Biospecimen Collection, Cisplatin - Basaloid Squamous Cell Carcinoma, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Phase 2 / Phase 3Active not recruitingNational Cancer Institute (NCI)3842019-10-092026-07-02
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
Carboplatin, Cisplatin, Docetaxel - Stage III Sinonasal Squamous Cell Carcinoma AJCC v6 and v7, Stage IVA Sinonasal Squamous Cell Carcinoma AJCC v7
Phase 2Active not recruitingECOG-ACRIN Cancer Research Group822019-03-122026-09-14
Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Fluorouracil, Gemcitabine, Image Guided Radiation Therapy - Pancreatic Adenocarcinoma, Resectable Pancreatic Carcinoma
Phase 2CompletedOHSU Knight Cancer Institute202016-01-212023-09-06
Radiation Therapy vs. Observation Following Gemcitabine and Cisplatin for Inoperable Localized Liver Cancer
Image Guided Radiation Therapy - Stage III Intrahepatic Cholangiocarcinoma, Stage IVA Intrahepatic Cholangiocarcinoma
Phase 3TerminatedNRG Oncology12014-09-292026-07-13
Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
3-Dimensional Conformal Radiation Therapy, Carboplatin, Image Guided Radiation Therapy - Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Non-Small Cell Cancer AJCC v7
Phase 1TerminatedNational Cancer Institute (NCI)162013-10-282023-05-06
Image-Guided, Intensity-Modulated Photon or Proton Beam Radiation Therapy in Treating Patients With Stage II-IIIB Non-small Cell Lung Cancer
Image Guided Radiation Therapy, Intensity-Modulated Radiation Therapy, Laboratory Biomarker Analysis - Recurrent Lung Non-Small Cell Carcinoma, Stage II Non-Small Cell Lung Cancer AJCC v7
Phase 1 / Phase 2Active not recruitingM.D. Anderson Cancer Center1462012-09-172026-09-16
Hypofractionated Radiation Therapy in Prostate Cancer
Intensity modulated radiation therapy, Volumetric modulated arc therapy, Image guided radiation therapy - Malignant Neoplasm of Prostate, Local Disease
Not applicableUnknownThomas Zilli1702012-09-012020-05-19
Development of Real-time Image-guided Radiotherapy
Image guided radiation therapy - Breast Cancer, Lung Cancer
Not applicableTerminatedFox Chase Cancer Center1592012-05-172020-03-02

Conditions studied

Squamous Cell Carcinoma of Head and Neck (3)  ·  Carcinoma (2)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Hypopharyngeal Neoplasms (2)  ·  Laryngeal Neoplasms (2)  ·  Lung Neoplasms (2)  ·  Mouth Neoplasms (2)  ·  Oropharyngeal Neoplasms (2)  ·  Breast Neoplasms (1)  ·  Carcinoma, Squamous Cell (1)  ·  Cholangiocarcinoma (1)  ·  Nasopharyngeal Carcinoma (1)  ·  Neoplasm Metastasis (1)  ·  Prostatic Neoplasms (1)  ·  Skin Neoplasms (1)

Sponsors

NRG Oncology (3)  ·  National Cancer Institute (NCI) (3)  ·  ECOG-ACRIN Cancer Research Group (2)  ·  City of Hope Medical Center (1)  ·  Fox Chase Cancer Center (1)  ·  M.D. Anderson Cancer Center (1)  ·  OHSU Knight Cancer Institute (1)  ·  Sean Sachdev (1)  ·  Thomas Zilli (1)  ·  University Health Network, Toronto (1)

Countries

United States (12)  ·  Canada (5)  ·  Australia (1)  ·  Belgium (1)  ·  Finland (1)  ·  Israel (1)  ·  Netherlands (1)  ·  Portugal (1)  ·  Spain (1)  ·  Switzerland (1)  ·  Turkey (Türkiye) (1)

Top investigators

Charles B Simone (1)  ·  David M Brizel (1)  ·  Gina Vaccaro (1)  ·  Heath D Skinner (1)  ·  Nabil F Saba (1)  ·  Neil D Gross (1)  ·  Sean Sachdev (1)  ·  Steven H Lin (1)  ·  Sue S Yom (1)  ·  Theodore Hong (1)  ·  Thomas Zilli, Dr (1)  ·  Yi-Jen Chen (1)  ·  Zhongxing Liao (1)

Results publications

PMID 26503201, PMID 35080076, PMID 39615497, PMID 41137728

NIH funding

U10CA180868 (4), U10CA180820 (2), P01CA021239 (1), P30CA016672 (1), P30CA033572 (1), P30CA060553 (1), P50CA070907 (1), U01CA062461 (1), U19CA021239 (1), UG1CA189867 (1), UM1CA186688 (1), UM1CA186712 (1)